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Abstract
1 he OH-CRC is an NIH In/nor/tv funded ,nfrastructure
program at the Unvorsitr of Halvan in partnersh/p uith
H 0au & i r Tue
ourpcse of the OH-CRC is to foster ciineal ‘esesrch
at OH ‘n Order to IrnoroVe the health of the ctzens of
Han ali. particularly those ivhosutferolspropOrtlunare!V
from disorders atfocting tnese corr’muri:lies This
status reoorf otocuments tue contfnued success and
oroqress of the Center Manuscripts published or IC
ni ess have increased from an average of 3 n years
1-3 to 54 in years 4-6 to 84 for years 7-9. Actual dol
lars received per year ranged from 1-7 million dollars
the first 6 years, but reached 8-22 million dollars the
last three years. This status report also documents
the mandate for this clinical research infrastructure
program to compete successfully for mainstream
funding status by 2010
Introduction
This is a progress report of the University of Hawaii
Clinical Research Center ([H—CRC) over the last
three ears. It is the third written report since the
[IRC was funded in 19’)S. The first report’ de
scri bed the origin’, of the [H—CRC. and the second
was a xix year progress report. Since 2001. progress
has continued and as a result, the UH-CRC is closer
to competing for mainstream funding for a General
Clinical Research Center GCRC). In contrast to
the minority funded status of the present [511-CRC,
a GCRC (both are funded by the National Center for
Research Resources I NCRRj) is a competitive main
stream clinical research infrastructure prouram that
provides for a much higher funding limit, and greater
resources and opportunities for research des elopment
which include core laboriitorv facilities. Reaching
this goal will not onl\ deirionstrate that this JABSOM
program is capable of attaining this higher les el of
success, but it xx ill also indicate the potential fAr a
long—term commitment ftom the NCRR to clinical
research development at [H.
Id summarize, the [H-CRC, with its outpatient
clinic located at Kapiolani Medical Center for Women
and Children fKMCWC) and its administrative
office located at the Gold Bond Building, both in
Honolulu. wa.s in,tiall dcx eloped as a collaborative
program between the Pacific Biomedical Research
Center (PBRC), John A. Burns School of rsfedicmne
(JABSOM I.and Kapiolani Health (nowcalled Hawaii
Pacific Health For the past nine years, the [H—CRC
has been nationally funded bs tsxo consecutive five
year grants awaided b the Research Center’. in Minor—
itv Institutions t RCMI I program of the NCRR. one
of 25 research institutes of the National Institutes of
Health I NIH. This year. ear ten. the focus of atten
tion is the reness al application to fund the Center for
the nest five years to 2010. It is within the timing
of this next cycle that the Center xv ill be expected to
transition into a successful GCRC.
The overall objectives of the UH-CRC have re
mained unchanged. It is to promote and conduct
clinical research at UH to mccl the health needs of
Hawaii s diverse population Acknowledging the
diversity of ethnic eroups throughout the state and
the disproportionate burden ofdisease upon particular
groups. the [H—CRC strives to fosterclinieal research
that reduces disparities between and amongst such
peoples. This objective is accomplished through the
provision of infrastructures uppor of junmorand minor—
it investigators as thex foi’ge their clinical research
careers, thereby increasing the quality and quantity
of meritorious research projects, and by facilitating
educational opportunities for students and established
healthcare providers throughout the state,
UH-CRC infrastructure support is offered on a
priority basis to investigators xx ith RO I—level funded
studies (NIH funding for established investigators.
and secondarilx to investigators supported by career
development awards and other programs of research
that support junior facultx des elopment The [H—
CRC also supports pilot pro(ects. especially those that
denmonsi rate xi rong potential 6 r e \ tramural tim ndi np
Finally, the [H-CRC’ supports linhior fac uitx xx hose
clinical research studies are a component requireiltent
in the Masters in Clinical Research Program. This
clinical research training and education program is
part ofJABSOM s overall strategy to expand the pool
of competent clinical investigators with independent
funding (See Fig I ) The UH-CRC provides qualified
investigators access toclinical and laboratory facilities.
support in protocol design. cpidemiologieal and hio
statistical analx xis. data /mnal\ sis. slhecinmemmcolleetlon
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and analysis, and administrative and clerical support
along with funding for study related expenses.
While emphasizing the last 3 years. the data pre
sented helo\\ represents the cutnulati e activity of
nine \ears of [‘H—CRC acti\ it\, as reflected in the
graphs and tables.
Methods
Data utilized in this report was compiled from writ
ten and computer generated reports collected as part
of the Annual Report. \vhich in turn is submitted to
the NIH. These reports ere collected by [H-CRC
research staff and FR—CRC in estigalors. The [H—
CRC study coordinators collect demographic and
research data such as target and actual enrollment
çby ethnicity and gender) from specific science and
administrative databases that have layered security
at the file/group/domain levels. These data were
reviewed by the authors of this report. and tables and
fIgures were generated from the raw data, No statisti
cal analysis was required for this studs.
Results
Over the tirst nine years. a total of I 55 applications
for research funding have been submitted to the U H—
CRC. The [‘H-CRC requires that applications include
research hypotheses, background and significance.
prel i minar\ results, the research design and methods.
adescription ofdata—produeing instruments, andasta—
tistleal anal sis. Submission rates has e risen steadily
os erthe first six ears. largely areflection ofthe number
of ins estigators who needed first—time support. New
submission rates have declined somewhat in the latter
years due to the UH—CRC s increased concentration
and focus on extramurally funded investigators and
their complex and infrastructure consuming studies.
As evidenced below, the UH-CRC has uttered support
in diverse research areas (See Fig. 2).
UH-CRC support has contributed to consistent
publication rates, as shown in Figure 3. Table I offers
exairiples of recent publications. Giants submitted
and ass arded by UH—CRC investigators have also
continued to increase, particularly since UH—CRC
investigators have focused their efilirts ipon health
disparities research (See Fig. 4 shoss ing the total dol—
I us ass arded . including the amount ass arded for all
ears ol multi—i ear erants i. Indeed. early lundine
receis ed trom research grants has climbed steadily
user the last three ears See Fig. 5i. [he underlying
nnmherol grantshas varied from 9. I u. and 27 invears
-3 to 35. 23. and 23 in years 4-6 to I 3. and 19 in
years ‘-9. Examples of recent grunts and investiga
tors) include A Stud\ of Oral Health Disparities in
Adult Asian & Pacific Islanders Easa and Harrigani,
Collaborative Alcohol Research Des elopment and
Planning I Ciochert
.
Female Pubei’t\
— A Multiethnic
C’uhort Study (Novotnv ), Mechanical and Infection
Pathwa s to Preterni Birth 13rvant—Gieenwoodi. Multiethnic Cohort Study of Diet
and Cancer Le Marchand i. Peridontal Disease in Diabetic \Vomen ss oh Preterm
Birth ) \Iillari. Stud of Cellular Mechanisnis ol Lung Gross th: Eflect of’ \K(’C
Cotransporter Inhibition on Lung (‘elI Proliferation C lwamotoe Mobile Access
Resource Prolect ) MARP C (Jacobs). Des elopment of Gene Transfer Approaches
for NeuroAl DS I .u i. and the Masters of Science in Clinical Research I larrigan
and Easa - t Ii is i’ a clinical research trai iii ne a nd ed neat ion avv ard I.
Other achies einents include an increased number of scientific seminars and
colloquia, along ss ith an increased number ii’ isiting scientists. In year fi. br
example. t’H—(’R( sponsored tvo ss orkshops. a short course, and a seminar ‘cries:
no more than I ‘r 2 such activities were sponsoi’cd in previous years. Distinguished
sctvntlsts s isitin in SC ir 9 md hclpin. I [-I ( R( to cvpand its clinic ml ip iit\
CRC supported pilot studies
in Clinical Research
Career Development (eg. K23)
‘I,
Independent Funding (R series)
F’cure 1.— Clinical Resea”cb Faculty Development This diagram shows The clint
ca research faculty developmeit orocess at UH. Pilot studies :ead o ‘nterest in the
Master’s in Clinical Resea”cb Program Curriculum. This provides unior faculty with the
tools to become successful investigators n clinical research. allowing them to compete
for career development grants ard eventually become independent nvestigators. The
CRC supports this process at all levels. CRC= Clinical Research Center.
-.5
Pediatrics
19%
I ‘‘ . 9
FigJ”e 2.— Grant Year 9 Areas of ac: \‘e research tas o Februa”\.’ 2004 (rz53 studies
ic uoina pilot stud•es:• CAM Oomo’ementary and Ate native Med me HlV Human
lrimunodeficiency Virus
Basic Science
9%
1,ijE[4CA(Jfl’pFP(4.
. 24)4 114 41/11 21)1)2
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include Drs. Diane Wara and Steven Hulley from the
University of California at San Francisco, and Dr.
Richard Galhraith from the University of Vermont,
Along with these achievements, the UH-CRC has
hired skilled technical personnel. two of whom were
Research Subjects \ds ocates (RSA) hlling ne’s
created positions. \-enkataraman Balaraman .NI1), and
Kari Kim. a nationally certified Institutional Review
Board ( IRB Professional, were appointed as the [H-
CRC s RSAs in 2001. The RSA position is separate
from the IRB and the RSAs are not IRB emplo ees.
Their primary purpose is to ensure that ever [H—
CRC supported research proeet protects the rights of
human subjects in clinical research. The also report
any problems ss tth research procedures. review IR[3
documents, help ss ith consent forms. reviess SAC
(Scientific Ads isor Committee) documents, and
assist with data safet monitoring plans. RSAs are
the link between the UK-CRC and the IRB. Finally.
the UWCRC s clinical research environment has new
creative opportunities torexpansion. Queens s Medi
cal Center. Leahi Hospital. the University of Hawaii
at Manoa and Kapiolani Community College are all
potential sites for clinical research activity.
The UH-CRC has improved its infrastructure, as
measured by increased proficiency for grants and
contracts management. Indeed. JABSOM has cre
ated a newl structured Grants Development Office
to facilitate research proposal development for the
UH-CRC and JABSOM s clinical investigators. The
Grants Development office provides the following
services: budget pi’epn’ition. preparation of biographi
cal sketches. grants writing, completion of Unisersit
forms (i.e.. Conflict of Interest. ORS—5 ). assistance
with letters ofsupport. es iew and consultation related
to proposal narrative, proposal packaging. dLipltcation
and mailing of proposal. and institutional reviess of
proposal.
Although the UK—CRC has improved its infrastruc
ture, there continue to bechallenges. includingaccom
modating forthe dramatic increase in clinical research
activity during the past year. Indeed. the volume of
research participant visits conducted during Grant
Year 9 represents a hO% increase and Grant Year 8 a
49U increase over Grant Year 7. These participant
visits all represent substantial increases from scar
I: in absolute numbers. isits increased from 4Sfi
in year I to 3.092 in ear 9. However, staffing and
space have not entirelx kept pace with demands. In
addition, housing of clinical and administrati\ e staff
in separate locations contmues to pose operational
challenges. This hjs been further exacerbated h the
move of UH—CR( administrative staff to the Gold
Bond B n Id i rig Jan uar\ . 2004 whic Ii is now 3 in i Ic’.
asva from the clinical unit at KYICWC. Indeed. nas ci
time kr meetings detracts from other duties such :Ls
implementation of studies. Operating from separate
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Figure 4— Total Value of Grant Awards including the amounts awarded for all years of
multi-year grants (as of February 2004)
2 3 4 5 6 7 8 9’
Grant Year
128
facilities has also resulted in inelficiencies related to
duplication of tiles, records, and administratis e pro
cesses. However, the strategic benefit of relocation
to the Gold Bond Building is to position JAI3SO\I
research programs and departments. including the
[H-CRC, to he located near the new medical school
building. the completion of \\ hich is anticipated in
Summer 2015
As for training and education programs designed to
increasethecritical massofqualified clinical investiga
tors, Dr. Easa. Dr. Rosanne Harrigan and the [H—CRC
prepared a successful NIH application to establish a
Master of Science in Clinical Research at JABSOM.
The Masters Program provides the necessary tools to
junior and minority faculty through a specific curricu—
lum and a reqLnred research studs in order to prepare
them for careers in clinical research.
Health disparities research continues to he a major
focus for the [H-CRC. For example. the Program
Director of the [H—CRC. Dr. Da id Easa. along
with eo—in estigators including Dr. Harrigan. were
successful in an R—2 I application, an application for
explorator and developmental research, entitled. “A
Study of Oral Health Disparities in Adult Asian &
Pacific Islanders, the objective of which was to apply
a state—of—the—art, molecular and epidemiological ap
proach to examining oral health disparities in Adult
Asian and Pacific Islanders. In addition. Dr. Easa and
the UH-CRC. s ho assisted with the successful Hawaii
EXPORT Center application .are now supporting the
program by fulfilling biostatistical and computer spe
cialist needs. The Hawaii EXPOR1’ Program is led hr
Dr. Marjorie Man, and is a community based research
program in diabetes targeted to Native Hax aiian and
Pacitie peoples. The [H-CRC has demonstrated
its eomnlmtmcnt to eoliahoraii\ c health disparities
research through continued interaction with several
Community Health Centers and other University of
Hawaii research institutes.
Discussion
The [H—CRC has continued to make pi’ogress over its
nine year hmstor as evidenced b the data presented
here. The current renewal application in prepai’a—
non vil I fund the [H—CRC tbr the next live sears.
The four speci tie amu’ include: I Increasing the
number of Rh I—level investigators at the [H—CRC:
2 Expanding career development programs to in
crease the number of clinical ins estivators at L H: ii
Improving [H—CRC infrastructure in order to better
support i nnos alive research: and 4 Strengthenin
collaborations designed to benefit Hawaii s diverse
communities. Included in the competitive renewal
application will heaproposal toineludeaCore Labora
tory at Queen s Medical Center. This will incorporate
Dr. Linda [hang s Magnetic Resonance (MR) facility
and researe 11 program. Dr. 1 nda [hang s area ii
525.000000 T
$20 000.000
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Table 1.— Examples of year 9 publications supported by the University of Hawaii Clini
cal Research Center
BrizzoiaraS. Piflai-AllenA. Riskof mesh. erosionwith sacral colpopexvandconcurrent hysterectomy Obstetncs
and Gynecology, 2003 Aug:i 0212i:306-31 0.
Brown AC, Valiere A. Prohiotics and Medical Nutrition Therapy. Nutr Clin Care Apr-June. 2004:7(2): 56-68
-
Davis J. Busch J. Hammatt Z, Novotny R. Harrigan R. Grandinetti A. Easa D. The relationship between
ethnicity and obesity in Asian and Pacific Islander populations: a literature review Ethnicity and Disease.
2004:14:11)-i 18.
Deraut C, Katz AR. Easa D. Agreement between maternal reported ethanol and tobacco use during preg
nancy and meconium assays for fatty acid ethyi esters and cotinine. American Journal of Epidemiology.
2003:1 58(7):705-709.
_____________
_______________
___________________
Hernandez BY. McDufhe K. Wilkens LR. Kamerroto L Goodman MT. Diet and prema0gnant lesions of the
cerv.x. euiderce Qf a protectve role fc.r alate dc1avm. thamm. vilam;n Bi 2 Cancer Causes and: Condo.
2003:14Wt:859-8T0
Hang TK. Uyenara CFT. Ba:araman V Masato CY. Haley TF. Egan E. Persc DA. Easa D. Surfactant
-r e S dca “-n c Jrrr “- n wptc fer HC gcpd 5nj ,r n
20O4’i82’ :15-25
u’.amctc L.’i. Put ‘am N Nasamura KE Wada RK Na-K-2C! oot’an.scorter btc cars human crc
celluar pro eraucr Am 3 Pbso oung Cell Mo Pnvso:: 287 tSi 0-4. 2001
Maskarinec C. Roonors C. R:oa B. Kane-Sample L Franks AA Murphy S. Three measures show ncr
compliance in a soy i.ntersention among premenopausai women. Journal of the American Dietetic Associa
tion. 2003:103(7):86i-866.
_________________
_________________
Sato RL. Wong 33, Sumida SM, Marn RY, Enoki NR. Yamamoto LG. Efficacy of superactivated charcoal
aomnisereo lath (3 ‘o Jrs after ncetaminopren
- dose Awe can Journal rr Emergency Meocne
2003;21i3):i89-191.
_____ ______
_____
____________ _
Novofny R DaidaYG. GroveJS, AcharyaS, VogtTM. Formula feeding in infancy is associated with adolescent
body fat and eaGer mermrche. Cellular and Molecuiar B:ology 2003:48(8r1289’1223,
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interest is the effect of substance abuse drugs on central nervous
system function. The MR scanner is an outstanding and innovative
tool to define functional defects resulting from drugs that are subject
to abuse. The competitive rcncn al application also emphasizes
areas of scienti tic focus including health di span tics research, early
human dcselopmcnt. maternal child health. cancer. cardiovascular
disease and related risks. neuroscicnces. oral health and emerging
infectious disease.
The goal tbr the next fine nears of the LH—CRC is to resols e
several key issues to make it competitive for GCRC status. F()r
example. an RU I or comparably funded clinical investigator must
he recruited to qualify as Program Director. The UH-CRC must
also expand the strength and depth of clinical research activit nn ith
at least twent\ studies that han e extramural funding. In order to
achieve this goal. more focus must be placed on R(> I inn estigators.
The UH—CRC also needs to identify and continue to broaden the
base of clinical investigators to include those from other hospitals
and healthcare organizations in Hawaii.
In sum, the RCMI-supported U H-CRC has demonstrated its abil
ity to progress and prosper to increase clinical research capacity in
the State of Hawaii. The number of UH—CRC—supported clinical
in\esttgators. research studies, publications, and research grants
continues to increase. (iivcn the UH-CRC s increasing capacity to
support meritorious research studies and funded investigators, it is
well positioned to compete forGCRC status sometime in the future.
This will become a nealitn given the opportunity to do so nn ith the
funding of the UH—CRC renewal application for a final five year
cycle.
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